{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:47Z","timestamp":1792088207012,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biopha.2017.02.010","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T10:52:16Z","timestamp":1487587936000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats"],"prefix":"10.1016","volume":"89","author":[{"given":"Samia Salem","family":"Sokar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda El-Sayed","family":"El-Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai El-Sayed","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhadi Mohamed","family":"Shebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.02.010_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-009-0080-9","article-title":"Antifibrotic therapies: will we ever get there?","volume":"12","author":"Thompson","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.biopha.2017.02.010_bib0010","doi-asserted-by":"crossref","first-page":"d69","DOI":"10.2741\/887","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","volume":"8","author":"Gabele","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biopha.2017.02.010_bib0015","first-page":"361","article-title":"Molecular pathogenesis of liver fibrosis","volume":"120","author":"Brenner","year":"2009","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"issue":"Suppl. 3","key":"10.1016\/j.biopha.2017.02.010_bib0020","first-page":"S84","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jep.2006.07.042","article-title":"Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats","volume":"109","author":"Lee","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/S0004-28032008000200013","article-title":"Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats","volume":"45","author":"Pereira-Filho","year":"2008","journal-title":"Arq. Gastroenterol."},{"issue":"6","key":"10.1016\/j.biopha.2017.02.010_bib0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2009.09.008","article-title":"A novel model of CCl4-induced cirrhosis with ascites in the mouse","volume":"51","author":"Domenicali","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0040","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1039\/b300099k","article-title":"Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum)","volume":"1","author":"Kim","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.biopha.2017.02.010_bib0045","first-page":"1986","article-title":"Effect of silybin on the hepatic microsomal drug metabolizing enzyme system in the rat","volume":"24","author":"Down","year":"1974","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biopha.2017.02.010_bib0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/138920112798868818","article-title":"Silymarin in the prevention and treatment of liver diseases and primary liver cancer","volume":"13","author":"F\u00e9her","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1472-8206.1989.tb00449.x","article-title":"Prevention of CCl4-induced liver cirrhosis by silymarin","volume":"3","author":"Mourelle","year":"1989","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc07-0233","article-title":"Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications","volume":"30","author":"Ahren","year":"2007","journal-title":"Diabetes. Care."},{"key":"10.1016\/j.biopha.2017.02.010_bib0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2008.08.012","article-title":"The incretin system and its role in type 2 diabetes mellitus","volume":"297","author":"Holst","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0167-4781(92)90036-Y","article-title":"Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface","volume":"1131","author":"Misumi","year":"1992","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.biopha.2017.02.010_bib0075","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagonlike peptide 1 in vitro and in vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"issue":"Suppl. 3","key":"10.1016\/j.biopha.2017.02.010_bib0080","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.2337\/diabetes.51.2007.S434","article-title":"The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion","volume":"51","author":"MacDonald","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2017.02.010_bib0085","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2174\/0929867033456648","article-title":"Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus","volume":"10","author":"Holz","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2017.02.010_bib0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidylpeptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.biopha.2017.02.010_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/0-387-32824-6_5","article-title":"Structure and function in dipeptidyl peptidase IV and related proteins","volume":"575","author":"Gorrell","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/bj2620327","article-title":"Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix","volume":"262","author":"Piazza","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2017.02.010_bib0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0168-8278(97)80180-8","article-title":"Aberrant dipeptidyl peptidase IV (DPP IV\/CD26) expression in human hepatocellular carcinoma","volume":"27","author":"Stecca","year":"1997","journal-title":"J.Hepatol"},{"key":"10.1016\/j.biopha.2017.02.010_bib0110","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/003655201750313423","article-title":"Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C","volume":"36","author":"Firneisz","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","article-title":"Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection","volume":"22","author":"Levy","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.biopha.2017.02.010_bib0120","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/hep.20853","article-title":"Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.02.010_bib0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2362.2000.00698.x","article-title":"Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis","volume":"30","author":"Lakatos","year":"2000","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.biopha.2017.02.010_bib0130","first-page":"729","article-title":"Increased hepatic expression of dipeptidylpeptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism","volume":"5","author":"Miyazaki","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2017.02.010_bib0135","first-page":"72","article-title":"Investigation of hepatoprotective effect of Foeniculum vulgare fixed oil in rats","volume":"1","author":"\u00d6zbek","year":"2006","journal-title":"Res. J. Med. Med. Sci"},{"key":"10.1016\/j.biopha.2017.02.010_bib0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats","volume":"49","author":"Kaji","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.taap.2011.02.004","article-title":"Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis","volume":"252","author":"Shaker","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(79)90708-7","article-title":"Lipid peroxidation in maternal and cord blood and protective mechanism against activatedoxygen toxicity in blood","volume":"135","author":"Yoshioka","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide."},{"key":"10.1016\/j.biopha.2017.02.010_bib0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfahydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2017.02.010_bib0165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1440-1746.2005.03901.x","article-title":"Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability","volume":"20","author":"Lee","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0170","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.biopha.2017.02.010_bib0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jep.2013.10.025","article-title":"Ashvagandharishta prepared using yeast consortium from Woodfordia fruticosa flowers exhibit hepatoprotective effect on CCl4 induced liver damage in Wistar rats","volume":"151","author":"Bhondave","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhazmat.2011.08.027","article-title":"Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4)","volume":"195","author":"Karakus","year":"2011","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.biopha.2017.02.010_bib0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5551\/jat.6189","article-title":"Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward","volume":"18","author":"Turgut","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.biopha.2017.02.010_bib0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/20014091084227","article-title":"Gamma glutamyl transferase","volume":"38","author":"Whitfield","year":"2001","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.biopha.2017.02.010_bib0200","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.eclnm.2011.12.004","article-title":"Evaluation of the hepatoprotective effect of green tea extract and selenium on CCl4-induced fibrosis","volume":"7","author":"Mahmoud","year":"2012","journal-title":"e-SPEN J."},{"key":"10.1016\/j.biopha.2017.02.010_bib0205","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.5754\/hge11263","article-title":"Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type2 diabetes mellitus","volume":"58","author":"Iwasaki","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.biopha.2017.02.010_bib0210","first-page":"240","article-title":"Effects of sitagliptin in diabetic patients with non-alcoholic steatohepatitis","volume":"75","author":"Yilmaz","year":"2012","journal-title":"Acta. Gastroenterol. Belg."},{"key":"10.1016\/j.biopha.2017.02.010_bib0215","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.12659\/MSM.890989","article-title":"DPP-4inhibitors improve liver dysfunction in type2 diabetes mellitus","volume":"20","author":"Kanazawa","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2017.02.010_bib0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2893.2008.00971.x","article-title":"Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Tsai","year":"2008","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.biopha.2017.02.010_bib0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1665-2681(19)31570-4","article-title":"Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats","volume":"10","author":"Ahmed","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0230","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/med.20115","article-title":"Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads","volume":"28","author":"Negi","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2017.02.010_bib0235","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.fct.2010.12.006","article-title":"Effects of standardized bilberry fruit extract (Mirtoselect1) on resolution of CCl4-induced liver fibrosis in mice","volume":"49","author":"Domitrovi\u0107","year":"2011","journal-title":"Food. Chem. Toxicol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0240","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1515\/znc-2001-7-826","article-title":"Mechanism of carbon tetrachlorideinduced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites","volume":"56","author":"Boll","year":"2001","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.biopha.2017.02.010_bib0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0250","doi-asserted-by":"crossref","first-page":"592760","DOI":"10.1155\/2010\/592760","article-title":"Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)","volume":"2010","author":"Ferreira","year":"2010","journal-title":"Mediators. Inflamm."},{"key":"10.1016\/j.biopha.2017.02.010_bib0255","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2369-14-98","article-title":"Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney","volume":"14","author":"Joo","year":"2013","journal-title":"BMC. Nephrol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0260","doi-asserted-by":"crossref","first-page":"424813","DOI":"10.1155\/2015\/424813","article-title":"Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in rats: impact of oxidative stress, inflammation, and apoptosis","volume":"2015","author":"Kelleni","year":"2015","journal-title":"J. Toxicol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0265","doi-asserted-by":"crossref","first-page":"e0144509","DOI":"10.1371\/journal.pone.0144509","article-title":"Free radical-scavenging, anti-inflammatory\/anti-fibrotic and hepatoprotective actions of taurine and silymarin against CCl4 induced rat liver damage","volume":"10","author":"Abdel-Moneim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.02.010_bib0270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1742-7843.2007.00069.x","article-title":"Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes","volume":"100","author":"Kiruthiga","year":"2007","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0275","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","article-title":"Silybin a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells","volume":"50","author":"Trappoliere","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0280","doi-asserted-by":"crossref","first-page":"d1899","DOI":"10.2741\/A887","article-title":"Chemokines in liver inflammation and fibrosis","volume":"7","author":"Marra","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biopha.2017.02.010_bib0285","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jlb.66.4.601","article-title":"Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice","volume":"66","author":"Natsume","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13098-015-0095-3","article-title":"DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats","volume":"7","author":"Alam","year":"2015","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2017.02.010_bib0295","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2147\/DDDT.S109287","article-title":"Sitagliptin attenuates cardiomyopathy by modulating the JAK\/STAT signaling pathway in experimental diabetic rats","volume":"10","author":"Al-Rasheed","year":"2016","journal-title":"Drug. Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2017.02.010_bib0300","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth. Factors."},{"key":"10.1016\/j.biopha.2017.02.010_bib0305","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jmf.2013.0179","article-title":"Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl4-treated rats","volume":"18","author":"Clichici","year":"2015","journal-title":"J. Med. Food."},{"key":"10.1016\/j.biopha.2017.02.010_bib0310","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues","volume":"112","author":"Jamall","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.02.010_bib0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040457","article-title":"Experimental models of hepatic fibrosis: a review","volume":"10","author":"Tsukamoto","year":"1990","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biopha.2017.02.010_bib0320","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.510290631","article-title":"Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis","volume":"29","author":"Levy","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.02.010_bib0325","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2474-12-113","article-title":"Reversal of TGF-\u03b21 stimulation of \u03b1-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren\u2019s-derived fibroblasts","volume":"12","author":"Satish","year":"2011","journal-title":"BMC. Musculoskelet. Disord."},{"key":"10.1016\/j.biopha.2017.02.010_bib0330","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2011.05.023","article-title":"The antifibrotic effects of TGF-beta1 siRNA on hepatic fibrosis in rats","volume":"409","author":"Lang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2017.02.010_bib0335","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/acer.12167","article-title":"TGF-\u03b21 up-regulates theexpression of PDGF-\u03b2 receptor mRNA and induces a delayed PI3K- AKT-, and p70S6K- dependent proliferative response in activated hepatic stellate cells","volume":"37","author":"Shah","year":"2013","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2017.02.010_bib0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2017.02.010_bib0345","doi-asserted-by":"crossref","first-page":"e0156090","DOI":"10.1371\/journal.pone.0156090","article-title":"Involvement of TGF-\u03b21\/Smad3 signaling in carbon tetrachloride-Induced acute liver injury in mice","volume":"11","author":"Niu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.02.010_bib0350","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2010.08.064","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes","volume":"213","author":"Ta","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.02.010_bib0355","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.jid.5701104","article-title":"Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloidderived skin fibroblasts","volume":"128","author":"Thielitz","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2017.02.010_bib0360","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jsfa.4723","article-title":"Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis","volume":"92","author":"Chen","year":"2012","journal-title":"J. Sci. Food."},{"key":"10.1016\/j.biopha.2017.02.010_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-3305-5-9","article-title":"Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis","volume":"5","author":"El-Lakkany","year":"2012","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.biopha.2017.02.010_bib0370","first-page":"1383","article-title":"Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts","volume":"47","author":"Fuchs","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biopha.2017.02.010_bib0375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0676.1991.tb00499.x","article-title":"Appearance of alpha-smooth muscle actin positive cells in hepatic fibrosis","volume":"11","author":"Nouchi","year":"1991","journal-title":"Liver"},{"key":"10.1016\/j.biopha.2017.02.010_bib0380","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.20425","article-title":"Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats","volume":"40","author":"Parsons","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.02.010_bib0385","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2009.07.015","article-title":"(\u2212)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R","volume":"182","author":"Yasuda","year":"2009","journal-title":"Chem. Biol. Interact."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216318923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216318923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:05:41Z","timestamp":1760094341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216318923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":77,"alternative-id":["S0753332216318923"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.010","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}